Advancements in Patient Care

In 2021, Providence Holy Cross was officially designated the number one treating facility in the United States for the Y90, a procedure that targets tumors from within its feeding blood vessels, with a high dose of radiation without affecting other, healthy parts of the body. Y90 refers to the radioactive isotope Yttrium-90. 

Holy Cross is the only hospital in Providence Southern California that offers this procedure. If you would like to have a consult with Dr. Eghbalieh, please email him at: Navid.Eghbalieh@providence.org or call 818-496-4530.

Watch this brief video to learn more.

Our Financial Health
Regional Chief Executive Kevin Manemann shares important information about Providence’s financial health and wellbeing. Learn about the impacts and what role you can play in our recovery process.
Advancements in Screening and Treatment
New technology changes the face of lung cancer diagnosis and treatment. Andrew Brownlee, MD, thoracic surgeon, uses a robotic-assisted endoluminal platform for minimal invasive lung biopsy.
COVID-19 Update
Charles Bailey, MD, infection prevention specialist provides the latest information on COVID-19, including the BA.2 “stealth” variant.
Advancements in Patient Care
Liver-directed therapy with Y90 is a relatively new, safe and highly successful treatment for cancer in the liver. Dr. Eghbalieh shares how this process is transforming how we treat liver cancers.
Powered by Translations.com GlobalLink Web SoftwarePowered by GlobalLink Web